The Medication Affordability and Patent Integrity Act is designed to enhance transparency and integrity in the drug approval process by mandating that drug sponsors and holders of approved applications share accurate patent information with the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO). This legislation aims to foster fair competition in the pharmaceutical industry and potentially lower drug prices by ensuring that patent claims are clear and consistent.